Overactive bladder: strategies to ensure treatment compliance and adherence

被引：17
作者：
Dhaliwal, Prabhpreet [1 ]
Wagg, Adrian [1 ]
机构：
[1] Univ Alberta, Dept Med, 1-108 Clin Sci Bldg,11350-83 Ave, Edmonton, AB T6G 2P4, Canada
来源：
CLINICAL INTERVENTIONS IN AGING | 2016年 / 11卷
关键词：
overactive bladder; persistence; adherence; URINARY-TRACT SYMPTOMS; QUALITY-OF-LIFE; MEDICATION ADHERENCE; CONTINENCE SOCIETY; IMMEDIATE-RELEASE; EXTENDED-RELEASE; PERSISTENCE; INCONTINENCE; INTERVENTIONS; THERAPY;
D O I：
10.2147/CIA.S69636
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Overactive bladder is a common, debilitating condition for many patients who may benefit from pharmacological management of their condition. However, adherence to medication in this condition is markedly worse than other chronic medical conditions. This review explores what is known about persistence and the factors which influence medication adherence for overactive bladder, those factors that might be modifiable to improve adherence, and the measures the health care provider can take to optimize adherence to therapy and thereby improve treatment outcomes.
引用
收藏
页码：755 / 760
页数：6
相关论文
共 58 条
  • [1] Factors involved in the success of antimuscarinic treatment
    Abrams, P
    Larsson, G
    Chapple, C
    Wein, AJ
    [J]. BJU INTERNATIONAL, 1999, 83 : 42 - 47
  • [2] Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and Treatment of Urinary Incontinence, Pelvic Organ Prolapse, and Fecal Incontinence
    Abrams, P.
    Andersson, K. E.
    Birder, L.
    Brubaker, L.
    Cardozo, L.
    Chapple, C.
    Cottenden, A.
    Davila, W.
    de Ridder, D.
    Dmochowski, R.
    Drake, M.
    DuBeau, C.
    Fry, C.
    Hanno, P.
    Smith, J. Hay
    Herschorn, S.
    Hosker, G.
    Kelleher, C.
    Koelbl, H.
    Khoury, S.
    Madoff, R.
    Milsom, I.
    Moore, K.
    Newman, D.
    Nitti, V.
    Norton, C.
    Nygaard, I.
    Payne, C.
    Smith, A.
    Staskin, D.
    Tekgul, S.
    Thuroff, J.
    Tubaro, A.
    Vodusek, D.
    Wein, A.
    Wyndaele, J. J.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2010, 29 (01) : 213 - 240
  • [3] The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society (Reprinted from Neurourology and Urodynamics, vol 21, pg 167-178, 2002)
    Abrams, P
    Cardozo, L
    Fall, M
    Griffiths, D
    Rosier, P
    Ulmsten, U
    Van Kerrebroeck, P
    Victor, A
    Wein, A
    [J]. UROLOGY, 2003, 61 (01) : 37 - 49
  • [4] Abrams P, 2000, AM J MANAG CARE, V6, pS580
  • [5] Al-Hajje Amal, 2015, Pharmacy Pract (Granada), V13, DOI 10.18549/PharmPract.2015.03.590
  • [6] DISCONTINUATION OF ANTIHYPERLIPIDEMIC DRUGS - DO RATES REPORTED IN CLINICAL-TRIALS REFLECT RATES IN PRIMARY-CARE SETTINGS
    ANDRADE, SE
    WALKER, AM
    GOTTLIEB, LK
    HOLLENBERG, NK
    TESTA, MA
    SAPERIA, GM
    PLATT, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (17) : 1125 - 1131
  • [7] [Anonymous], 2010, POP PROJ CAN PROV TE
  • [8] [Anonymous], 2013, UR INC WOM MAN UR IN
  • [9] Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: A longitudinal cohort study
    Balkrishnan, R
    Bhosle, MJ
    Camacho, FT
    Anderson, RT
    [J]. JOURNAL OF UROLOGY, 2006, 175 (03) : 1067 - 1071
  • [10] Balkrishnan R., 2006, J UROLOGY, V175, P1071
123456